Neurable has completed a $35m Series A funding round to expedite the commercialisation of its patented compact brain-signal processing technology, Neurable AI, which integrates brain-computer interface (BCI) offerings into commonly used devices.
With this latest round, the total funding raised by the company now stands at $65m.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Spectrum Moonshot Fund spearheaded the round, which is aimed at supporting Neurable’s efforts to bring its neurotechnology out of the laboratory into everyday routines.
Last year, Neurable launched the MW75 Neuro LT BCI-enabled headphones and an updated app that delivers cognitive data, including cognitive recovery, mental fatigue, and focus state detection in real-time.
The company plans to use the Series A financing to broaden its neurotechnology platform within the cognitive health and human performance sectors.
A key area of focus for Neurable is gaming and e-sports, where improvements in concentration, reaction time, and cognitive endurance can influence competitive results.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNeurable co-founder and CEO Dr Ramses Alcaide said: “Our mission is to make understanding your brain as natural and intuitive as checking your steps.
“With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone.”
The company is also expanding its presence in research applications and new BCI-enabled product categories.
Recently, Neurable teamed up with a human behaviour research platform, iMotions, to integrate its headsets into the iMotions software suite, allowing researchers and product teams in capturing neural data at scale.
In October 2025, Neurable partnered with MeSpace to study the impact of adaptive workstations on cognitive performance.
Together, MeSpace and Neurable completed an initial research study comparing traditional open offices with MeSpace workstations, examining how workspace design impacts real-time brain activity.
Neurable focuses on developing AI-driven tools for brain signal translation and BCI technology.
